66 research outputs found
Experience of being chair and co-chair of the ECMC and reasons why you should be the NEXT
In this article, we provide an overview of the experience of being chair and co-chair of the Early Career Member Committee (ECMC) of the European Respiratory Society (ERS) from past and current officers â Niki Ubags (past chair), Maxime Patout (past co-chair), Sara Cuevas Ocaña (current chair) and Thomas Gille (current co-chair) (figure 1). The past chair and co-chair share their main achievements and challenges as leaders of the ECMC, and how the position has impacted (or is impacting) their career. The current chair and co-chair provide their view of the ECMC for the future and the goals to achieve during their mandate.We also outline the ERS Networking EXcellence Training (NEXT) programme and provide testimonials from ERS members who were invited to participate in the first edition of the programme, and selected to present their work in the Science slam session at the ERS Congress 2022. Find out the reasons why you should be NEXT
Nasal versus oronasal masks for home non-invasive ventilation in patients with chronic hypercapnia:a systematic review and individual participant data meta-analysis
BACKGROUND: The optimal interface for the delivery of home non-invasive ventilation (NIV) to treat chronic respiratory failure has not yet been determined. The aim of this individual participant data (IPD) meta-analysis was to compare the effect of nasal and oronasal masks on treatment efficacy and adherence in patients with COPD and obesity hypoventilation syndrome (OHS). METHODS: We searched Medline and Cochrane Central Register of Controlled Trials for prospective randomised controlled trials (RCTs) of at least 1âmonth's duration, published between January 1994 and April 2019, that assessed NIV efficacy in patients with OHS and COPD. The main outcomes were diurnal PaCO2, PaO2 and NIV adherence (PROSPERO CRD42019132398). FINDINGS: Of 1576 articles identified, 34 RCTs met the inclusion criteria and IPD were obtained for 18. Ten RCTs were excluded because only one type of mask was used, or mask data were missing. Data from 8 RCTs, including 290 IPD, underwent meta-analysis. Oronasal masks were used in 86% of cases. There were no differences between oronasal and nasal masks for PaCO2 (0.61 mm Hg (95%âCI -2.15 to 3.38); p=0.68), PaO2 (-0.00 mm Hg (95%âCI -4.59 to 4.58); p=1) or NIV adherence (0·29âhour/day (95%âCI -0.74 to 1.32); p=0.58). There was no interaction between the underlying pathology and the effect of mask type on any outcome. INTERPRETATION: Oronasal masks are the most used interface for the delivery of home NIV in patients with OHS and COPD; however, there is no difference in the efficacy or tolerance of oronasal or nasal masks
Evaluation of new techniques for the diagnosis and the management of chronic respiratory failure
Lâinsuffisance respiratoire chronique est un syndrome dĂ©fini par une dĂ©faillance monoviscĂ©ralerespiratoire. Sa principale origine est aujourdâhui le syndrome obĂ©sitĂ©-hypoventilation qui concerne 4 Ă 5% des patients obĂšses. LâIRC est aussi le stade Ă©volutif terminal de la bronchopneumopathie chronique obstructive qui touche 6 Ă 8% de la population adulte. Lâincidence de ces pathologies et donc de lâinsuffisance respiratoire est en augmentation constante. Dans cette thĂšse, nous avons Ă©valuĂ© les nouvelles modalitĂ©s diagnostiques et thĂ©rapeutiques qui pourraient amĂ©liorer la prise en charge des patients atteints dâinsuffisance respiratoire chronique.Concernant la prise en charge diagnostique, nous avons montrĂ© que les donnĂ©es fournies par lâĂ©lectromyographie de surface des muscles intercostaux, outil qui Ă©value le travail respiratoire, constituent un marqueur pronostique indĂ©pendant chez les patients atteints de bronchopneumopathie chronique obstructive. Nous avons Ă©galement montrĂ© leur pertinence pour prĂ©dire lâefficacitĂ© clinique et lâobservance Ă la ventilation non-invasive Ă domicile.Concernant la prise en charge thĂ©rapeutique, nous avons montrĂ© que lâutilisation dâun mode semi-automatisĂ© de ventilation non-invasive a la mĂȘme efficacitĂ© que celle de modes classiques en permettant une mise en place plus rapide du traitement. Nous avons Ă©galement rapportĂ© lâintĂ©rĂȘt de lâoxygĂ©nothĂ©rapie Ă haut dĂ©bit au domicile alors que ce traitement Ă©tait utilisĂ© jusque-lĂ dans le seul cadre des soins intensifs. Enfin, nous avons rapportĂ© les bĂ©nĂ©fices de la pression positive continue au cours de lâeffort chez les patients ayant une trachĂ©obronchomalacie. Concernant le suivi des patients, nous avons montrĂ© que les donnĂ©es des logiciels de ventilation non invasive permettent de prĂ©dire la survenue dâune exacerbation sĂ©vĂšre de BPCO mais que lâutilisation de la tĂ©lĂ©mĂ©decine chez les patients insuffisants respiratoires chroniques ne peut ĂȘtre encore pleinement intĂ©grĂ©e dans la pratique clinique. Au cours de cette thĂšse, nous avons identifiĂ© de nouveaux outils physiologiques, de nouvelles modalitĂ©s dâadministration des traitements et de nouveaux outils de suivi Ă domicile, Ă mĂȘme dâamĂ©liorer la prise en charge des patients insuffisants respiratoires chroniques.Single-organ respiratory failure defines chronic respiratory failure. Obesity hypoventilation syndrome is the main cause of chronic respiratory failure and occurs in 4 to 5% of obese patients. Chronic respiratory failure is also the end-stage evolution of chronic obstructive pulmonary disease that has a prevalence of 6 to 8% in the adult population. The incidence of these diseases increases so does the incidence of chronic respiratory failure. In this thesis, we will evaluate novel diagnostic and therapeutic modalities that could improve the care of patients with chronic respiratory failure. Regarding diagnostic modalities, we have seen that evaluating the work of breathing with surface parasternal electromyography was an independent prognostic marker in patients with chronic obstructive pulmonary disease. We have also seen that it was a relevant tool to predict the clinicalefficacy and compliance to home non-invasive ventilation. Regarding therapeutic modalities, we have shown that the use of a semi-automatic mode of non-invasive ventilation had the same efficacy of a standard mode with a shorter length of stay for its setup. We have shown the relevance and feasibility of the use of high-flow oxygen therapy in the home setting whilst it was only used in intensive care units. Finally, we have shown the benefits of continuous positive airway pressure during exertion in patients with tracheobronchomalacia. Regarding patientsâ follow-up, we have shown that the use of data from built-in software could predict the onset of a severe exacerbation of chronic obstructive pulmonary disease. However, we also show that the implementation of tele-medicine in patients with chronic respiratory failure cannot be included in daily clinical practice yet. In this thesis, we have identified novel physiological tools, novel ways to administer treatments and novel follow-up tools that can improve the management of patients with chronic respiratory failure
Evaluation des techniques pour la prise en charge diagnostique et thérapeutique de l'insuffisance respiratoire chronique
Single-organ respiratory failure defines chronic respiratory failure. Obesity hypoventilation syndrome is the main cause of chronic respiratory failure and occurs in 4 to 5% of obese patients. Chronic respiratory failure is also the end-stage evolution of chronic obstructive pulmonary disease that has a prevalence of 6 to 8% in the adult population. The incidence of these diseases increases so does the incidence of chronic respiratory failure. In this thesis, we will evaluate novel diagnostic and therapeutic modalities that could improve the care of patients with chronic respiratory failure. Regarding diagnostic modalities, we have seen that evaluating the work of breathing with surface parasternal electromyography was an independent prognostic marker in patients with chronic obstructive pulmonary disease. We have also seen that it was a relevant tool to predict the clinicalefficacy and compliance to home non-invasive ventilation. Regarding therapeutic modalities, we have shown that the use of a semi-automatic mode of non-invasive ventilation had the same efficacy of a standard mode with a shorter length of stay for its setup. We have shown the relevance and feasibility of the use of high-flow oxygen therapy in the home setting whilst it was only used in intensive care units. Finally, we have shown the benefits of continuous positive airway pressure during exertion in patients with tracheobronchomalacia. Regarding patientsâ follow-up, we have shown that the use of data from built-in software could predict the onset of a severe exacerbation of chronic obstructive pulmonary disease. However, we also show that the implementation of tele-medicine in patients with chronic respiratory failure cannot be included in daily clinical practice yet. In this thesis, we have identified novel physiological tools, novel ways to administer treatments and novel follow-up tools that can improve the management of patients with chronic respiratory failure.Lâinsuffisance respiratoire chronique est un syndrome dĂ©fini par une dĂ©faillance monoviscĂ©ralerespiratoire. Sa principale origine est aujourdâhui le syndrome obĂ©sitĂ©-hypoventilation qui concerne 4 Ă 5% des patients obĂšses. LâIRC est aussi le stade Ă©volutif terminal de la bronchopneumopathie chronique obstructive qui touche 6 Ă 8% de la population adulte. Lâincidence de ces pathologies et donc de lâinsuffisance respiratoire est en augmentation constante. Dans cette thĂšse, nous avons Ă©valuĂ© les nouvelles modalitĂ©s diagnostiques et thĂ©rapeutiques qui pourraient amĂ©liorer la prise en charge des patients atteints dâinsuffisance respiratoire chronique.Concernant la prise en charge diagnostique, nous avons montrĂ© que les donnĂ©es fournies par lâĂ©lectromyographie de surface des muscles intercostaux, outil qui Ă©value le travail respiratoire, constituent un marqueur pronostique indĂ©pendant chez les patients atteints de bronchopneumopathie chronique obstructive. Nous avons Ă©galement montrĂ© leur pertinence pour prĂ©dire lâefficacitĂ© clinique et lâobservance Ă la ventilation non-invasive Ă domicile.Concernant la prise en charge thĂ©rapeutique, nous avons montrĂ© que lâutilisation dâun mode semi-automatisĂ© de ventilation non-invasive a la mĂȘme efficacitĂ© que celle de modes classiques en permettant une mise en place plus rapide du traitement. Nous avons Ă©galement rapportĂ© lâintĂ©rĂȘt de lâoxygĂ©nothĂ©rapie Ă haut dĂ©bit au domicile alors que ce traitement Ă©tait utilisĂ© jusque-lĂ dans le seul cadre des soins intensifs. Enfin, nous avons rapportĂ© les bĂ©nĂ©fices de la pression positive continue au cours de lâeffort chez les patients ayant une trachĂ©obronchomalacie. Concernant le suivi des patients, nous avons montrĂ© que les donnĂ©es des logiciels de ventilation non invasive permettent de prĂ©dire la survenue dâune exacerbation sĂ©vĂšre de BPCO mais que lâutilisation de la tĂ©lĂ©mĂ©decine chez les patients insuffisants respiratoires chroniques ne peut ĂȘtre encore pleinement intĂ©grĂ©e dans la pratique clinique. Au cours de cette thĂšse, nous avons identifiĂ© de nouveaux outils physiologiques, de nouvelles modalitĂ©s dâadministration des traitements et de nouveaux outils de suivi Ă domicile, Ă mĂȘme dâamĂ©liorer la prise en charge des patients insuffisants respiratoires chroniques
Towards Context-Aware Automated Writing Evaluation Systems
Writing is a crucial skill in our society, which is regularly exerted by students across all disciplines. Automated essay scoring and automatic writing evaluation systems can support professors in the evaluation of written texts and, conversely, help students improving their writing. However, most of those systems fail to consider the context of the writing, such as the targeted audience and the genre. In this paper, we depict our vision towards new-generation AES systems that could evaluate written products while considering their specific context. In education, such tools could support students not only in adapting their written product to their particular context, but also in identifying points for improvement and situational settings where their writing is less proficient.info:eu-repo/semantics/inPres
A dynamical model for patient-ventilator interactions during noninvasive ventilation
International audienc
Higher baseline heart rate variability in CCHS patients with progestin-associated recovery of hypercapnic ventilatory response
Abstract After a fortuitous observation of two cases of chemosensitivity recovery in women with congenital central hypoventilation syndrome (CCHS) who took desogestrel, we aimed to evaluate the ventilatory response to hypercapnia of five CCHS patients with or without treatment consisting of desogestrel (DESO) or levonorgestrel (LEVO). Only two patients became responsive to hypercapnia under treatment, according to their basal vagal heart rate variability. These results suggest that heart rate variability may be promising tool to discriminate patients susceptible to become responsive to hypercapnia under DESO-LEVO treatment. Clinical Trials Identifier NCT0124369
Efficacy of a home discharge care bundle after acute exacerbation of COPD
International audienceAcute exacerbations of COPD (AECOPD) are frequent and associated with a poor prognosis. A home discharge care bundle, the PRADO-BPCO program, has been set up by the French National Health System in order to reduce readmission rate after hospitalization for AECOPD. This program includes early consultations by the general practitioner, a nurse, and a physiotherapist after discharge. The aim of our study was to evaluate the effect of the PRADO-BPCO program on the 28-days readmission rate of COPD patients after hospitalization for AECOPD
Interstitial lung disease-related pneumomediastinum in COVID-19 patients
International audiencePneumomediastinum in severe #COVID19 presentations could be due to a lung parenchymal retractive process generated by intense inflammation as in acute exacerbation of idiopathic pulmonary fibrosis or MDA-5 acute interstitial lung disease
- âŠ